Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00262-002-0273-7.

Title:
A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation | Cancer Immunology, Immunotherapy
Description:
The detection and monitoring of peptide-specific cytotoxic T lymphocyte (CTL) precursors is essential for successful peptide-based immunotherapy against cancers. In contrast to the development of effective methods of detecting antigen-specific CTL, such as ELISpot and HLA-class I tetramer assay, stimulation with peptide-pulsed antigen-presenting cells (APC) has for some time been conventionally employed to induce peptide-specific CTL from peripheral blood mononuclear cells (PBMC). This culture protocol, however, needs a substantial number of PBMC to test the reactivity against a panel of peptides. In the present study, we established a simple culture protocol which has no need of additional APC. Addition of a corresponding peptide every 3 days was found to induce not only Epstein–Barr virus (EBV)-specific CTL from healthy donors, but also tumor antigen-derived peptide-specific CTL from cancer patients. A 10-ml blood sample was almost sufficient to test the presence of CTL precursors against 20 different peptides in triplicate assays. Overall, this culture protocol can be useful in detecting and monitoring peptide-specific CTL precursors in the circulation in peptide-based immunotherapy against cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Technology & Computing
  • Telecommunications
  • Non-Profit & Charity

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

article, ctl, culture, peptidespecific, privacy, cookies, content, cancer, immunotherapy, protocol, cytotoxic, precursors, peptide, access, information, publish, search, lymphocyte, data, log, journal, research, immunology, simple, circulation, hida, maeda, katagiri, cells, discover, japan, springer, essential, optional, personal, parties, policy, find, track, detect, june, cite, naoya, yoshiaki, kazuko, hideo, takasu, mamoru, harada, kyogo,

Topics {✒️}

peptide-pulsed antigen-presenting cells mamoru harada & kyogo itoh detect peptide-specific cytotoxic successful peptide-based immunotherapy month download article/chapter induce peptide-specific ctl detecting antigen-specific ctl peptide-specific cytotoxic peptide-based immunotherapy privacy choices/manage cookies related subjects full article pdf article cancer immunology simple culture protocol 10-ml blood sample 0201-restricted ctl epitope european economic area hideo takasu epstein–barr virus kurume university school conditions privacy policy accepting optional cookies june 2002 volume 51 specific ctl 0201-restricted cytotoxic journal finder publish immunotherapy article check access instant access article hida culture protocol naoya hida article log yoshiaki maeda ctl precursors additional apc peptide privacy policy personal data books a immunotherapy aims article cite optional cookies manage preferences cancer patients subscription content similar content data protection cookies skip institution subscribe

Schema {🗺️}

WebPage:
      mainEntity:
         headline:A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation
         description: The detection and monitoring of peptide-specific cytotoxic T lymphocyte (CTL) precursors is essential for successful peptide-based immunotherapy against cancers. In contrast to the development of effective methods of detecting antigen-specific CTL, such as ELISpot and HLA-class I tetramer assay, stimulation with peptide-pulsed antigen-presenting cells (APC) has for some time been conventionally employed to induce peptide-specific CTL from peripheral blood mononuclear cells (PBMC). This culture protocol, however, needs a substantial number of PBMC to test the reactivity against a panel of peptides. In the present study, we established a simple culture protocol which has no need of additional APC. Addition of a corresponding peptide every 3 days was found to induce not only Epstein–Barr virus (EBV)-specific CTL from healthy donors, but also tumor antigen-derived peptide-specific CTL from cancer patients. A 10-ml blood sample was almost sufficient to test the presence of CTL precursors against 20 different peptides in triplicate assays. Overall, this culture protocol can be useful in detecting and monitoring peptide-specific CTL precursors in the circulation in peptide-based immunotherapy against cancer.
         datePublished:
         dateModified:
         pageStart:219
         pageEnd:228
         sameAs:https://doi.org/10.1007/s00262-002-0273-7
         keywords:
            CTL Immunotherapy Peptide Vaccine
            Oncology
            Immunology
            Cancer Research
         image:
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:51
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Naoya Hida
               affiliation:
                     name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
                     address:
                        name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yoshiaki Maeda
               affiliation:
                     name:First Department of Surgery, Hokkaido University Graduate School of Medicine, N15W7, Sapporo, Hokkaido 060-8638, Japan
                     address:
                        name:First Department of Surgery, Hokkaido University Graduate School of Medicine, N15W7, Sapporo, Hokkaido 060-8638, Japan,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kazuko Katagiri
               affiliation:
                     name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
                     address:
                        name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hideo Takasu
               affiliation:
                     name:Sumitomo Pharmaceutical Osaka, Kasugaidenaka 3-1-98, Konohana-ku, Osaka 554-0022, Japan
                     address:
                        name:Sumitomo Pharmaceutical Osaka, Kasugaidenaka 3-1-98, Konohana-ku, Osaka 554-0022, Japan,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mamoru Harada
               affiliation:
                     name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
                     address:
                        name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kyogo Itoh
               affiliation:
                     name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
                     address:
                        name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation
      description: The detection and monitoring of peptide-specific cytotoxic T lymphocyte (CTL) precursors is essential for successful peptide-based immunotherapy against cancers. In contrast to the development of effective methods of detecting antigen-specific CTL, such as ELISpot and HLA-class I tetramer assay, stimulation with peptide-pulsed antigen-presenting cells (APC) has for some time been conventionally employed to induce peptide-specific CTL from peripheral blood mononuclear cells (PBMC). This culture protocol, however, needs a substantial number of PBMC to test the reactivity against a panel of peptides. In the present study, we established a simple culture protocol which has no need of additional APC. Addition of a corresponding peptide every 3 days was found to induce not only Epstein–Barr virus (EBV)-specific CTL from healthy donors, but also tumor antigen-derived peptide-specific CTL from cancer patients. A 10-ml blood sample was almost sufficient to test the presence of CTL precursors against 20 different peptides in triplicate assays. Overall, this culture protocol can be useful in detecting and monitoring peptide-specific CTL precursors in the circulation in peptide-based immunotherapy against cancer.
      datePublished:
      dateModified:
      pageStart:219
      pageEnd:228
      sameAs:https://doi.org/10.1007/s00262-002-0273-7
      keywords:
         CTL Immunotherapy Peptide Vaccine
         Oncology
         Immunology
         Cancer Research
      image:
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:51
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Naoya Hida
            affiliation:
                  name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
                  address:
                     name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yoshiaki Maeda
            affiliation:
                  name:First Department of Surgery, Hokkaido University Graduate School of Medicine, N15W7, Sapporo, Hokkaido 060-8638, Japan
                  address:
                     name:First Department of Surgery, Hokkaido University Graduate School of Medicine, N15W7, Sapporo, Hokkaido 060-8638, Japan,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kazuko Katagiri
            affiliation:
                  name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
                  address:
                     name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hideo Takasu
            affiliation:
                  name:Sumitomo Pharmaceutical Osaka, Kasugaidenaka 3-1-98, Konohana-ku, Osaka 554-0022, Japan
                  address:
                     name:Sumitomo Pharmaceutical Osaka, Kasugaidenaka 3-1-98, Konohana-ku, Osaka 554-0022, Japan,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mamoru Harada
            affiliation:
                  name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
                  address:
                     name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kyogo Itoh
            affiliation:
                  name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
                  address:
                     name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:51
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
      address:
         name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
         type:PostalAddress
      name:First Department of Surgery, Hokkaido University Graduate School of Medicine, N15W7, Sapporo, Hokkaido 060-8638, Japan
      address:
         name:First Department of Surgery, Hokkaido University Graduate School of Medicine, N15W7, Sapporo, Hokkaido 060-8638, Japan,
         type:PostalAddress
      name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
      address:
         name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
         type:PostalAddress
      name:Sumitomo Pharmaceutical Osaka, Kasugaidenaka 3-1-98, Konohana-ku, Osaka 554-0022, Japan
      address:
         name:Sumitomo Pharmaceutical Osaka, Kasugaidenaka 3-1-98, Konohana-ku, Osaka 554-0022, Japan,
         type:PostalAddress
      name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
      address:
         name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
         type:PostalAddress
      name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
      address:
         name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Naoya Hida
      affiliation:
            name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
            address:
               name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
               type:PostalAddress
            type:Organization
      name:Yoshiaki Maeda
      affiliation:
            name:First Department of Surgery, Hokkaido University Graduate School of Medicine, N15W7, Sapporo, Hokkaido 060-8638, Japan
            address:
               name:First Department of Surgery, Hokkaido University Graduate School of Medicine, N15W7, Sapporo, Hokkaido 060-8638, Japan,
               type:PostalAddress
            type:Organization
      name:Kazuko Katagiri
      affiliation:
            name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
            address:
               name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
               type:PostalAddress
            type:Organization
      name:Hideo Takasu
      affiliation:
            name:Sumitomo Pharmaceutical Osaka, Kasugaidenaka 3-1-98, Konohana-ku, Osaka 554-0022, Japan
            address:
               name:Sumitomo Pharmaceutical Osaka, Kasugaidenaka 3-1-98, Konohana-ku, Osaka 554-0022, Japan,
               type:PostalAddress
            type:Organization
      name:Mamoru Harada
      affiliation:
            name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
            address:
               name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
               type:PostalAddress
            type:Organization
      name:Kyogo Itoh
      affiliation:
            name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
            address:
               name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
      name:First Department of Surgery, Hokkaido University Graduate School of Medicine, N15W7, Sapporo, Hokkaido 060-8638, Japan,
      name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
      name:Sumitomo Pharmaceutical Osaka, Kasugaidenaka 3-1-98, Konohana-ku, Osaka 554-0022, Japan,
      name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
      name:Department of Immunology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan,
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(35)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.67s.